Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
3.110
-0.110 (-3.42%)
At close: Nov 13, 2026, 4:00 PM EST
2.950
-0.160 (-5.14%)
Pre-market: Nov 16, 2026, 7:29 AM EST

Entera Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
-0.040.18-0.130.57
Revenue Growth
--76.80%---76.53%56.44%
Cost of Revenue
-0.040.17-0.10.37
Gross Profit
--0.01-0.030.2
Selling, General & Admin
6.315.535.14.437.715.69
Research & Development
12.164.54.515.856.77
Other Operating Expenses
----0.05-0.05-0.05
Operating Expenses
18.4111.539.598.8913.5112.42
Operating Income
-18.41-11.53-9.59-8.89-13.47-12.22
Interest Expense
-11.05-----
Interest & Investment Income
0.030.090.060.03--
Currency Exchange Gain (Loss)
------0.03
Other Non Operating Income (Expenses)
----0.08-
EBT Excluding Unusual Items
-29.43-11.44-9.53-8.86-13.39-12.25
Other Unusual Items
----0.46-
Pretax Income
-29.43-11.44-9.53-8.86-12.93-12.25
Income Tax Expense
--0.010.030.14-0.06
Net Income
-29.43-11.44-9.54-8.89-13.07-12.19
Net Income to Common
-29.43-11.44-9.54-8.89-13.07-12.19
Net Income Growth
------
Shares Outstanding (Basic)
734638292926
Shares Outstanding (Diluted)
734638292926
Shares Change
64.72%22.68%29.79%0.69%10.23%41.90%
EPS (Basic)
-0.40-0.25-0.25-0.31-0.45-0.47
EPS (Diluted)
-0.40-0.25-0.25-0.31-0.45-0.47
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-15.84-7.48-6.82-7.33-12.55-9.08
Free Cash Flow Per Share
-0.22-0.16-0.18-0.25-0.44-0.35
Gross Margin
--4.97%-24.63%34.68%
Operating Margin
--27450.00%-5295.58%--10055.22%-2139.58%
Profit Margin
--27235.71%-5271.27%--9754.48%-2134.33%
Free Cash Flow Margin
--17802.38%-3768.51%--9362.69%-1590.19%
EBITDA
-18.38-11.5-9.54-8.84-13.41-12.16
D&A For EBITDA
0.030.030.050.060.060.05
EBIT
-18.41-11.53-9.59-8.89-13.47-12.22
SEC Filings: 10-K · 10-Q